Lawrence Metelitsa

Senior Associate representing clients in connection with general corporate and transactional matters, including mergers and acquisitions, corporate governance, corporate restructuring, corporate finance and specializing securities law, including the registration of securities under the Securities Act of 1933 and compliance with reporting requirements under the Exchange Act of 1934.

Practice also focuses on counseling public companies on mergers and acquisitions (including Reverse Mergers), Private Investment in Public Equity (PIPE) transactions, equity lines and corporate finance transactions.

Representative transactions:

Representation of a NJ-based AIM listed diagnostics company specializing in the development, manufacture, and supply of rapid, point-of-care screening and testing products in a $17,500,000 underwritten offering of its common stock and dual-listing onto the NASDAQ Global Select market

Representation of a NJ based manufacturer and marketer of specialty pre-prepared, frozen and refrigerated "all natural" food products in a reverse merger and $12,500,000 offering of the company’s common stock.

Representation of a broker-dealer in connection with a $3,000,000 private placement of certain equity securities, including the drafting of a Private Placement Memorandum, Subscription Agreement, Common Stock Purchase Warrant, Operating Agreement and Joinder Agreement.

Representation of a publicly-traded New York-based integrated marketing company in connection with a $2,000,000 Common Stock Purchase Agreement and the registration of the company’s common stock on a Form S-1 Registration Statement.

Representation of a private Nevada-based company specializing in mobile wagering in connection with a $1,100,000 private placement of certain debt securities, including a Subscription Agreement, Convertible Promissory Note and Common Stock Purchase Warrant.